CN102302619B - Medicine for treating gout - Google Patents
Medicine for treating gout Download PDFInfo
- Publication number
- CN102302619B CN102302619B CN2011101588642A CN201110158864A CN102302619B CN 102302619 B CN102302619 B CN 102302619B CN 2011101588642 A CN2011101588642 A CN 2011101588642A CN 201110158864 A CN201110158864 A CN 201110158864A CN 102302619 B CN102302619 B CN 102302619B
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- gout
- grams
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a Chinese medicine, in particular to a medicine for treating gout. The medicine can relieve toxic and side effects of reduced medicinal effects or serious adverse reactions generated by taking western medicines for a long time, is prepared from the following raw materials in part by weight: 10 to 36 parts of ampelopsis grossede, 20 to 50 parts of aspidopterys glabriuscula, 20 to 35 parts of giant knotweed rhizome and 10 to 30 parts of clerodendranthus spicatus, and is boiled in water and taken before dinner. The medicine for treating the gout has unique curative effects, is low in cost, addresses both the symptoms and root causes, does not have any side effect, improves purine metabolic disturbance fundamentally, and regulates the immune function of organisms comprehensively.
Description
Technical field
The present invention relates to a kind of Chinese medicine medicine, be specifically related to a kind of medicine of treating gout.
Background technology
Gout is long-term purine metabolism obstacle, and blood uric acid increases the one group of disease that causes tissue injury.The goat pathogenic factor be uricopoiesis too much or the RE uric acid reduce and cause that uric acid raises in the blood, formation of deposits uric acid crystal in articular cavity causes joint congestion and swelling pain and falls ill.Gout is the most often invaded the joint of big nurse toe root, but also is common in sufficient other position, knee joint, finger-joint, carpal joint and elbow joint.
Infringement is most commonly in the little joint of brothers to gout to osteoarthrosis, for preferably sending out the position, relates to joints such as ankle, knee joint, wrist with foot thumb joint later on.The joint caused inflammation of gout often breaks out, and the joint is red, swollen, hot, tenderness and severe pain are arranged, with night more so.Outbreak has General Symptoms such as fervescence often, leukocytosis, and erythrocyte sedimentation rate quickens, serum uric acid salinity rising etc.
Most of patients is taken indometacin, ibuprofen or metabolic medicine purine alcohol, the narcaricin etc. of pain relieving class, and traditional medicine makes that the patient takes medicine effectively, drug withdrawal is invalid, beginning effectively, invalid at last.And uric acid also can take place and causes gouty nephropathy and gout renal calculus in kidney deposition in the gout patient.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine folk medicine decoction of treating gout, special effect, treating both the principal and secondary aspects of a disease has no side effect, and is cheap, and fundamentally improves purine metabolic disturbance, the overall regulating immunity of organism function.
The invention provides a kind of medicine of treating gout, process: 10～36 parts of Ampelopsis grossedentata, 20～50 parts of Caulis Aspidopterydis obcordataes, 10～30 parts of 20～35 parts of Rhizoma Polygoni Cuspidati and Herba clerodendranthi spicati by following raw materials by weight portion.
Preferably, comprise the raw material of following weight ratio: 15～30 parts of Ampelopsis grossedentata, 27～38 parts of Caulis Aspidopterydis obcordataes, 14～23 parts of 18～31 parts of Rhizoma Polygoni Cuspidati and Herba clerodendranthi spicati.
The medicine of treatment gout provided by the invention, its configuration and instructions of taking are: be unit with the gram, make dose by the above-mentioned raw materials weight proportion, soaked 45 minutes with normal-temperature water, after big fire was boiled, little fiery decocting in water 35 minutes was poured out medicinal liquid; Medicinal residues add normal-temperature water again, and little fiery decocting in water 30 minutes is poured out medicinal liquid; Twice medicinal liquid amalgamation is risen, and part moisture is removed in little fire distillation, obtains the decoction of one day dose, takes at twice.The decoction that taking medicine before meal obtains with medicine of the present invention.Taking 30 days continuously is a course of treatment.
Medicine of the present invention contains Ampelopsis grossedentata, Caulis Aspidopterydis obcordatae, Rhizoma Polygoni Cuspidati, Herba clerodendranthi spicati, and these drug regimens make the effect of each medicine produce synergism, thereby can the efficacious therapy goat.
The pharmacological action of its crude drug is following:
Ampelopsis grossedentata: slightly sweet flavor, cool in nature.Have heat-clearing and toxic substances removing, fall summer-heat and promote the production of body fluid, wind-damp dispelling, bone and muscle strengthening, antiinflammatory diuresis, arrhythmia, resisting myocardial ischemia, effects such as alleviation of alcohol effect.
Caulis Aspidopterydis obcordatae: puckery, cold.The antiinflammatory diuresis, the heat clearing away calculus is controlled urinary tract infection, cystitis, lithangiuria, rheumatic ostalgia.
Rhizoma Polygoni Cuspidati: little hardship is slightly cold.Eliminating stasis to stop pain, expelling wind and removing dampness is controlled and is coughed only expectorant.
Herba clerodendranthi spicati: sweet in the mouth; Light; Little hardship; Cool in nature.Clearing away heat-damp and promoting diuresis; Tonglin Paishi.Refrigerant antiinflammatory is mainly used in treatment acute and chronic nephritis, cystitis, lithangiuria and rheumatic arthritis.
More than all medicines, tight combination, ingenious compatibility has the merit of clearing heat and expelling damp, promoting blood circulation to remove obstruction in the collateral and reducing swelling and alleviating pain, the stasis of blood is stagnated eliminate, and is damp and hot clearly, thereby makes gout be able to control, reaches the purpose of recovery from illness.
Advantage of the present invention is a reasonable recipe, medicine has no side effect, and the toxic and side effects that has overcome Western medicine in the past is big.The present invention adopts oral, and is easy to use, and cost is low, compares with the Chinese medicine preparation that similar Western medicine is stronger with containing toxicity, and it is rapid, evident in efficacy that it has a pain relieving, has no side effect, and the patient is prone to accept, suitable advantage such as take for a long time.
The present invention provides a kind of effect of drugs of treating gout remarkable, and the typical case of treatment has:
Case one, Liu Quan, man, 46 years old, billows people from Cang County, Yunnan.The patient on 09 13rd, 2010 ailing same day hospital treatment, gather serum sample, learn that from result of laboratory test the uric acid index is 756 μ mol/L, obviously exceed normal person's standard, be diagnosed as " gout ".Taking medicine decoction of the present invention after two courses of treatment, pain obviously weakens, and checks to hospital on November 15th, 2010, and result of laboratory test shows that the uric acid index is 519 μ mol/L.
Case two, Wu Zhengyang, man, 70 years old, Yunnan Yuxi people.The patient on 09 13rd, 2010 ailing same day hospital treatment, gather serum sample, learn that from result of laboratory test the uric acid index is 604 μ mol/L, obviously exceed normal person's standard, be diagnosed as " gout ".Taking medicine decoction of the present invention after course of treatment, pain obviously weakens, and checks to hospital on October 24th, 2010, and result of laboratory test shows that the uric acid index is 534 μ mol/L.
Specific embodiment
Embodiment 1
A kind of medicine of gout of treatment, it is to be processed by following raw materials in weight: Ampelopsis grossedentata 10 grams, Caulis Aspidopterydis obcordatae 20 grams, Rhizoma Polygoni Cuspidati 20 grams and Herba clerodendranthi spicati 10 grams.
Its configuration and instructions of taking are: earlier said components was soaked in water 45 minutes, decocting in water 35 minutes is poured out medicinal liquid; Medicinal residues added decocting in water 30 minutes again, poured out medicinal liquid; Twice medicinal liquid amalgamation is risen, and part moisture is removed in little fire distillation, obtains the potion decoction.The decoction that one after each meal medicine of the present invention obtains, day clothes potion, potion is taken at twice.Taking 30 days continuously is a course of treatment.
Embodiment 2
A kind of medicine of gout of treatment, it is to be processed by following raw materials in weight: Ampelopsis grossedentata 36 grams, Caulis Aspidopterydis obcordatae 50 grams, Rhizoma Polygoni Cuspidati 35 grams and Herba clerodendranthi spicati 30 grams.
Configuration and instructions of taking: with embodiment 1.
Embodiment 3
A kind of medicine of gout of treatment, it is to be processed by following raw materials in weight: Ampelopsis grossedentata 15 grams, Caulis Aspidopterydis obcordatae 27 grams, Rhizoma Polygoni Cuspidati 18 grams and Herba clerodendranthi spicati 14 grams.
Configuration and instructions of taking: with embodiment 1.
Embodiment 4
A kind of medicine of gout of treatment, it is to be processed by following raw materials in weight: Ampelopsis grossedentata 28 grams, Caulis Aspidopterydis obcordatae 38 grams, Rhizoma Polygoni Cuspidati 31 grams and Herba clerodendranthi spicati 23 grams.
Configuration and instructions of taking: with embodiment 1.
Embodiment 5
A kind of medicine of gout of treatment, it is to be processed by following raw materials in weight: Ampelopsis grossedentata 23 grams, Caulis Aspidopterydis obcordatae 35 grams, Rhizoma Polygoni Cuspidati 27 grams and Herba clerodendranthi spicati 20 grams.
Configuration and instructions of taking: with embodiment 1.
Claims (2)
1. a medicine of treating gout is characterized in that, it is to be processed by the following raw materials by weight portion proportioning: 10～36 parts of Ampelopsis grossedentata, 20～50 parts of Caulis Aspidopterydis obcordataes, 10～30 parts of 20～35 parts of Rhizoma Polygoni Cuspidati and Herba clerodendranthi spicati.
2. a kind of medicine of treating gout according to claim 1 is characterized in that, it is to be processed by the following raw materials by weight portion proportioning: 15～28 parts of Ampelopsis grossedentata, 27～38 parts of Caulis Aspidopterydis obcordataes, 14～23 parts of 18～31 parts of Rhizoma Polygoni Cuspidati and Herba clerodendranthi spicati.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101588642A CN102302619B (en) | 2011-06-14 | 2011-06-14 | Medicine for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101588642A CN102302619B (en) | 2011-06-14 | 2011-06-14 | Medicine for treating gout |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102302619A CN102302619A (en) | 2012-01-04 |
| CN102302619B true CN102302619B (en) | 2012-11-14 |
Family
ID=45376602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101588642A Expired - Fee Related CN102302619B (en) | 2011-06-14 | 2011-06-14 | Medicine for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102302619B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113209146B (en) * | 2021-05-31 | 2022-11-11 | 云南省中医中药研究院 | Application of scutellariae Siniperca extract in medicine for preventing and/or treating uric acid nephropathy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709480A (en) * | 2005-06-13 | 2005-12-21 | 四川禾正制药有限责任公司 | Chinese medicine composition for treating wrinary tract disease |
| CN101856388A (en) * | 2010-06-01 | 2010-10-13 | 新平彝族傣族自治县民族医药研究学会 | Medicament for treating urinary calculus and benign prostatic hyperplasia |
-
2011
- 2011-06-14 CN CN2011101588642A patent/CN102302619B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709480A (en) * | 2005-06-13 | 2005-12-21 | 四川禾正制药有限责任公司 | Chinese medicine composition for treating wrinary tract disease |
| CN101856388A (en) * | 2010-06-01 | 2010-10-13 | 新平彝族傣族自治县民族医药研究学会 | Medicament for treating urinary calculus and benign prostatic hyperplasia |
Non-Patent Citations (2)
| Title |
|---|
| 肾茶在泌尿系统疾病中的临床应用;蔡华芳;《中国医疗前沿》;20071231;第2卷(第总23期);3－4 * |
| 蔡华芳.肾茶在泌尿系统疾病中的临床应用.《中国医疗前沿》.2007,第2卷(第总23期),3－4. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102302619A (en) | 2012-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463381B (en) | Traditional Chinese medicine preparation for treating rheumatism bone pain and preparation method thereof | |
| CN103211932B (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN101134065A (en) | Traditional Chinese medicine for treating intestinal obstruction | |
| CN103990030A (en) | Internal medicine for treating gout and preparation method thereof | |
| CN102302619B (en) | Medicine for treating gout | |
| CN104667035A (en) | Medicament for treating gout | |
| CN101554398B (en) | Externally applied medical ointment for treating surgical infection and gout and preparation method thereof | |
| CN102526275B (en) | Pharmaceutical for curing gout and preparation method thereof | |
| CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
| CN102846750B (en) | Fengtongning composite preparation and preparation method thereof | |
| CN103393783B (en) | Composition containing resveratrol and application | |
| CN105412692A (en) | Traditional Chinese medicine preparation for treating arthroncus of knees | |
| CN105687672A (en) | Traditional Chinese medicine composition for treating mastitis and mammary gland hyperplasia and preparation method thereof | |
| CN105267321A (en) | Medicine for treating gouty arthritis | |
| CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
| CN103099999B (en) | Traditional Chinese medicine for treating gout disease | |
| CN105617161A (en) | Traditional Chinese medicine composition for treating gout | |
| CN103585483A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN103610914B (en) | A kind of internal traditional Chinese medicinal wine for the treatment of rheumatic arthritis | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN102716389B (en) | Externally dressed drug for treating gout | |
| CN101091742A (en) | Decoction medicine for treating acute mastadenitis, and preparation method | |
| CN102133322A (en) | Externally-applied traditional Chinese medicine composition for treating acute gouty arthritis and preparation method thereof | |
| Jing et al. | Advances in the Application of State-target Dialectical Theory in the Treatment of Gouty Diseases | |
| CN105435013A (en) | Traditional Chinese medicine enema powder used for treating chronic nonspecific ulcerative colitis, and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121114 Termination date: 20170614 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |